Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Aug 27, 2016; 8(8): 578-582
Published online Aug 27, 2016. doi: 10.4240/wjgs.v8.i8.578
Table 1 Comparison of patients’ characteristics n (%)
HALS-RP (n = 23)OPEN-RP (n = 24)P value
Age, mean42.7 ± 12.750.9 ± 18.1NS
Sex (male/female)15/818/6NS
BMI, kg/m220.8 ± 3.122.6 ± 3.30.043
ASA scoreNS
11 (4.3)1 (4.2)
222 (95.7)23 (95.8)
30 (0)0 (0)
Disease duration (month, median)132 (66-216)136 (36-256)NS
Extent of colitisNS
Pancolitis17 (73.9)16 (76.1)
Left side colitis6 (26.1)4 (19.0)
Rectal colitis0 (0)1 (4.8)
Indication for surgeryNS
Cancer/dysplasia6 (26.9)10 (41.6)
Stricture4 (17.4)2 (8.33)
Refractory to medication13 (56.5)10 (41.6)
Others0 (0)2 (4.26)
Preoperative medication
Corticosteroid (mg, median)4400 (1000-8700)950 (0-4462)NS
12 (50%)
L-CAP/G-CAP10 (434)12 (50)NS
CyA, Tarolimus3 (8.7)0 (0)NS
Biologics2 (8.7)3 (12.5)NS
Preoperative comorbidityNS
HT3 (13)4 (16.7)
DM1 (4.3)3 (12.5)
Preoperative laboratory data (average ± SD)
Leukocyte7486 ± 4785661 ± 4100.002
Hemoglobin11.8 ± 0.7413.05 ± 0.28NS
Serum albumin3.96 ± 0.114.16 ± 0.221NS
CRP1.42 ± 0.7490.29 ± 0.104NS
Table 2 Comparison of surgical outcome and complications
HALS-RP (n = 23)OPEN-RP (n = 24)P value
Surgical outcome
Operation time (min, median)369 (320-420)355 (318-421)NS
Blood loss (mL, median)300 (230-402)512 (401-1162)0.003
Bowel movement (d, mean)1.5 ± 0.131.8 ± 1.4NS
Toleration of liquids1.3 ± 0.131.29 ± 1.75NS
Toleration of solid diet5.26 ± 0.753.62 ± 0.29NS
Length of stay (d)20 (16-26)18 (14-29)NS
Complications, n (%)
IPAA anastomotic leak3 (13.04)2 (8.33)NS
Surgical site infection
Superficial wound infection3 (13.04)1 (4.17)NS
Deep wound infection0 (0)2 (8.3)NS
Organ space infection5 (21.7)4 (16.67)NS
Small bowel obstruction6 (26.0)4 (16.6)NS
Venous thromboembolism2 (8.7)3 (6.38)NS
Neurogic bladder dysfunction0 (0)1 (4.17)NS
Hemorrhage0 (0)1 (4.17)NS